Bacterial cell envelope and intracellular macromolecules

The bacterial cell envelope and intracellular macromolecules represent the fundamental structural and functional targets for the majority of antimicrobial therapies. The cell envelope, comprising the peptidoglycan cell wall and lipid membranes, is essential for maintaining osmotic pressure and selective permeability (StatPearls, 2023). Intracellular macromolecules, including DNA, RNA, and ribosomes, constitute the machinery required for the replication and expression of genetic information (Nature Reviews Microbiology, 2016). Antibiotics target these components through various mechanisms: beta-lactams inhibit cell wall cross-linking, polymyxins disrupt membrane stability, fluoroquinolones inhibit DNA gyrase, and macrolides bind to the 50S ribosomal subunit to halt protein synthesis (Merck Manual, 2024). These targets are clinically significant because their structural differences from human cells allow for selective toxicity in treating bacterial infections. However, the emergence of multi-drug resistance through target modification or efflux remains a major therapeutic challenge (WHO, 2023). This broad classification covers nearly all sites of action for current antibacterial drug classes, making it a composite rather than a single molecular target.

Other names

Bacterial cell wallBacterial cell membraneBacterial ribosomesBacterial nucleic acidsBacterial protein synthesis machinery

Inhibition of cell wall synthesis, disruption of cell membrane integrity, inhibition of protein synthesis via 30S or 50S ribosomal subunits, and inhibition of nucleic acid synthesis or function.